C. elegans: An all in one model for antimicrobial drug discovery

Current Drug Targets

Volumn 12, Issue 7, 2011, Pages 967-977

  Squiban, B ^a,b,c   Kurz, C Léopold ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Antimicrobial; C. elegans; High throughput; Infection; Pathogen; Screen

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BURKHOLDERIA PSEUDOMALLEI; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DRUG SCREENING; DRUG TARGETING; ENTEROCOCCUS FAECALIS; HOST PATHOGEN INTERACTION; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA TYPHIMURIUM; SERRATIA MARCESCENS; STRESS; SURVIVAL; VIBRIO CHOLERAE; VIRULENCE; YERSINIA PESTIS;

EID: 79958118223     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945011795677854     Document Type: Review

References (85)

1. Horvitz HR, Shaham S, Hengartner MO. The genetics of programmed cell death in the nematode Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol 1994; 59: 377-85.
2. Bargmann CI. Chemosensation in C. elegans: The C. elegans Research Community ed; 2006. Available from: http: //www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=Pub Med&dopt=Citation&list_uids=18050433.
3. Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol 2010; 10(1): 47-58.
4. Powell JR, Ausubel FM. Models of Caenorhabditis elegans Infection by Bacterial and Fungal Pathogens. In: Ewbank J, Vivier E, eds. Methods Mol Biol: Humana Press 2008; pp. 403-27.
5. Sulston JE, Schierenberg E, White JG, Thomson JN. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol. 1983; 100(1): 64-119.
6. Altun ZF, Hall DH. Handbook of C. elegans Anatomy 2005. Available from: http: //www.wormatlas.org/.
7. Tan MW, Mahajan-Miklos S, Ausubel FM. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci USA 1999; 96(2): 715-20.
8. Aballay A, Yorgey P, Ausubel FM. Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr Biol 2000; 10(23): 1539-42.
9. Labrousse A, Chauvet S, Couillault C, Kurz CL, Ewbank JJ. Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr Biol 2000; 10(23): 1543-5.
10. Kurz CL, Chauvet S, Andres E, et al. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J 2003; 22(7): 1451-60.
11. Alegado RA, Tan MW. Resistance to antimicrobial peptides contributes to persistence of Salmonella typhimurium in the C. elegans intestine. Cell Microbiol 2008; 10(6): 1259-73.
12. Evans TC, ed. Transformation and microinjection. In: Community TCeR, ed. WormBook: WormBook.
13. Stiernagle T. Maintenance of C. elegans. http: //www.wormbook.org: The C. elegans Research Community ed; 2006.
14. Duverger Y, Belougne J, Scaglione S, et al. A semi-automated high-throughput approach to the generation of transposon insertion mutants in the nematode Caenorhabditis elegans. Nucleic Acids Res 2007; 35(2): e11.
15. Lecuit M, Cossart P. Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol Med 2002; 8(11): 537-42.
16. Rahme LG, Stevens EJ, Wolfort SF, et al. Common virulence factors for bacterial pathogenicity in plants and animals. Science 1995; 268(5219): 1899-902.
17. Rahme LG, Tan MW, Le L, et al. Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors. Proc Natl Acad Sci USA 1997; 94(24): 13245-50.
18. Mahajan-Miklos S, Tan MW, Rahme LG, Ausubel FM. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 1999; 96(1): 47-56.
19. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci USA 1999; 96(5): 2408-13.
20. Gan YH, Chua KL, Chua HH, et al. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system. Mol Microbiol 2002; 44(5): 1185-97.
21. Poole K, Schiebel E, Braun V. Molecular characterization of the hemolysin determinant of Serratia marcescens. J Bacteriol 1988; 170(7): 3177-88.
22. Tenor JL, McCormick BA, Ausubel FM, Aballay A. Caenorhabditis elegans-based screen identifies Salmonella virulence factors required for conserved host-pathogen interactions. Curr Biol 2004; 14(11): 1018-24.
23. Garsin DA, Sifri CD, Mylonakis E, et al. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci USA 2001; 98(19): 10892-7.
24. Sifri CD, Mylonakis E, Singh KV, et al. Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun 2002; 70(10): 5647-50.
25. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci USA 2002; 99(24): 15675-80.
26. Mylonakis E, Idnurm A, Moreno R, et al. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 2004; 54(2): 407-19.
27. Styer KL, Hopkins GW, Bartra SS, et al. Yersinia pestis kills Caenorhabditis elegans by a biofilm-independent process that involves novel virulence factors. EMBO Rep 2005; 6(10): 992-7.
28. Vaitkevicius K, Lindmark B, Ou G, et al. A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci USA 2006; 103(24): 9280-5.
29. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009; 8(11): 1750-8.
30. Lu R, Maduro M, Li F, et al. Animal virus replication and RNAimediated antiviral silencing in Caenorhabditis elegans. Nature 2005; 436(7053): 1040-3.
31. Troemel ER, Felix MA, Whiteman NK, Barriere A, Ausubel FM. Microsporidia are natural intracellular parasites of the nematode Caenorhabditis elegans. PLoS Biol 2008; 6(12): 2736-52.
32. Couillault C, Ewbank JJ. Diverse Bacteria Are Pathogens of Caenorhabditis elegans. Infect Immun 2002; 70(8): 4705-7.
33. Lavigne JP, Nicolas-Chanoine MH, Bourg G, Moreau J, Sotto A. Virulent synergistic effect between Enterococcus faecalis and Escherichia coli assayed by using the Caenorhabditis elegans model. PLoS One 2008; 3(10): e3370.
34. Breger J, Fuchs BB, Aperis G, et al. Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay. PLoS Pathog 2007; 3(2): e18.
35. Bae T, Banger AK, Wallace A, et al. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci USA 2004; 101(33): 12312-7.
36. Shapira M, Hamlin BJ, Rong J, et al. A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci USA 2006; 103(38): 14086-91.
37. Tang RJ, Breger J, Idnurm A, et al. Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun 2005; 73(12): 8219-25.
38. Huffman DL, Bischof LJ, Griffitts JS, Aroian RV. Pore worms: using Caenorhabditis elegans to study how bacterial toxins interact with their target host. Int J Med Microbiol 2004; 293(7-8): 599-607.
39. Rubin GM, Yandell MD, Wortman JR, et al. Comparative genomics of the eukaryotes. Science 2000; 287(5461): 2204-15.
40. Lemaitre B, Hoffmann J. The Host Defense of Drosophila melanogaster. Annu Rev Immunol 2007; 25: 697-743.
41. Mallo GV, Kurz CL, Couillault C, et al. Inducible antibacterial defense system in C. elegans. Curr Biol 2002; 12(14): 1209-14.
42. Kim DH, Feinbaum R, Alloing G, et al. A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 2002; 297(5581): 623-6.
43. Couillault C, Pujol N, Reboul J, et al. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat Immunol 2004; 5: 488-94.
44. O'Rourke D, Baban D, Demidova M, Mott R, Hodgkin J. Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res 2006; 16(8): 1005-16.
45. Ziegler K, Kurz CL, Cypowyj S, et al. Antifungal innate immunity in C. elegans: PKCdelta links G protein signaling and a conserved p38 MAPK cascade. Cell Host Microbe 2009; 5(4): 341-52.
46. Shivers RP, Pagano DJ, Kooistra T, et al. Phosphorylation of the conserved transcription factor ATF-7 by PMK-1 p38 MAPK regulates innate immunity in Caenorhabditis elegans. PLoS Genet 2010; 6(4): e1000892.
47. Estes KA, Dunbar TL, Powell JR, Ausubel FM, Troemel ER. bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proc Natl Acad Sci USA 2010; 107(5): 2153-8.
48. Garsin DA, Villanueva JM, Begun J, et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 2003; 300(5627): 1921.
49. Nicholas HR, Hodgkin J. The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr Biol 2004; 14(14): 1256-61.
50. Kim DH, Liberati NT, Mizuno T, et al. Integration of Caenorhabditis elegans MAPK pathways mediating immunity and stress resistance by MEK-1 MAPK kinase and VHP-1 MAPK phosphatase. Proc Natl Acad Sci USA 2004; 101(30): 10990-4.
51. Zugasti O, Ewbank JJ. Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat Immunol 2009; 10(3): 249-56.
52. Aballay A, Ausubel FM. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc Natl Acad Sci USA 2001; 98(5): 2735-9.
53. Jia K, Thomas C, Akbar M, et al. Autophagy genes protect against Salmonella typhimurium infection and mediate insulin signalingregulated pathogen resistance. Proc Natl Acad Sci USA 2009; 106(34): 14564-9.
54. Kawli T, Tan MW. Neuroendocrine signals modulate the innate immunity of Caenorhabditis elegans through insulin signaling. Nat Immunol 2008; 9(12): 1415-24.
55. Troemel ER, Chu SW, Reinke V, et al. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genetics 2006; 2(11): e183.
56. Ferrandon D, Jung AC, Criqui M, et al. A drosomycin-GFP reporter transgene reveals a local immune response in Drosophila that is not dependent on the Toll pathway. Embo J 1998; 17(5): 1217-27.
57. Alper S, McBride SJ, Lackford B, Freedman JH, Schwartz DA. Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol Cell Biol 2007; 27(15): 5544-53.
58. Pujol N, Zugasti O, Wong D, et al. Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog 2008; 4(7): e1000105.
59. Evans EA, Kawli T, Tan MW. Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog 2008; 4(10): e1000175.
60. Huffman DL, Abrami L, Sasik R, et al. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Natl Acad Sci USA 2004; 101(30): 10995-1000.
61. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997; 61(2): 136-69.
62. Jansen WT, Bolm M, Balling R, Chhatwal GS, Schnabel R. Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus pyogenes. Infect Immun 2002; 70(9): 5202-7.
63. Pradel E, Zhang Y, Pujol N, et al. Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc Natl Acad Sci USA 2007; 104(7): 2295-300.
64. Garsin DA, Urbach J, Huguet-Tapia JC, Peters JE, Ausubel FM. Construction of an Enterococcus faecalis Tn917-mediated-genedisruption library offers insight into Tn917 insertion patterns. J Bacteriol 2004; 186(21): 7280-9.
65. Giacomotto J, Pertl C, Borrel C, et al. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy. Hum Mol Genet 2009; 18(21): 4089-101.
66. Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener Dis 2004; 1(4-5): 175-83.
67. Parker JA, Holbert S, Lambert E, Abderrahmane S, Neri C. Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans. J Mol Neurosci 2004; 23(1-2): 61-8.
68. Moy TI, Conery AL, Larkins-Ford J, et al. High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol 2009; 4(7): 527-33.
69. Partridge FA, Tearle AW, Gravato-Nobre MJ, Schafer WR, Hodgkin J. The C. elegans glycosyltransferase BUS-8 has two distinct and essential roles in epidermal morphogenesis. Dev Biol 2008; 317(2): 549-59.
70. Liao VH, Dong J, Freedman JH. Molecular characterization of a novel, cadmium-inducible gene from the nematode Caenorhabditis elegans. A new gene that contributes to the resistance to cadmium toxicity. J Biol Chem 2002; 277(44): 42049-59.
71. Kurz CL, Shapira M, Chen K, Baillie DL, Tan MW. Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochem Biophys Res Commun 2007; 363(2): 438-43.
72. Candido EP, Jones D. Transgenic Caenorhabditis elegans strains as biosensors. Trends Biotechnol 1996; 14(4): 125-9.
73. Custodia N, Won SJ, Novillo A, et al. Caenorhabditis elegans as an environmental monitor using DNA microarray analysis. Ann N Y Acad Sci 2001; 948: 32-42.
74. Moy TI, Ball AR, Anklesaria Z, et al. Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci USA 2006; 103(27): 10414-9.
75. Okoli I, Coleman JJ, Tampakakis E, et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 2009; 4(9): e7025.
76. Kurz CL, Ewbank JJ. Infection in a dish: high-throughput analyses of bacterial pathogenesis. Curr Opin Microbiol 2007; 10(1): 10-6.
77. Tampakakis E, Okoli I, Mylonakis E. A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds. Nat Protoc 2008; 3(12): 1925-31.
78. Gill MS, Olsen A, Sampayo JN, Lithgow GJ. An automated highthroughput assay for survival of the nematode Caenorhabditis elegans. Free Radic Biol Med 2003; 35(6): 558-65.
79. Irazoqui JE, Troemel ER, Feinbaum RL, et al. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog 2010; 6: e1000982.
80. Mahajan-Miklos S, Rahme LG, Ausubel FM. Elucidating the molecular mechanisms of bacterial virulence using nonmammalian hosts. Mol Microbiol 2000; 37(5): 981-8.
81. Buttner D, Bonas U. Port of entry--the type III secretion translocon. Trends Microbiol 2002; 10(4): 186-92.
82. Griffitts JS, Whitacre JL, Stevens DE, Aroian RV. Bt toxin resistance from loss of a putative carbohydrate-modifying enzyme. Science 2001; 293(5531): 860-4.
83. Daniells C, Duce I, Thomas D, et al. Transgenic nematodes as biomonitors of microwave-induced stress. Mutat Res 1998; 399(1): 55-64.
84. Peleg AY, Tampakakis E, Fuchs BB, et al. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci USA 2008; 105(38): 14585-90.
85. Ikeda T, Yasui C, Hoshino K, Arikawa K, Nishikawa Y. Influence of lactic acid bacteria on longevity of Caenorhabditis elegans and host defense against Salmonella enterica serovar enteritidis. Appl Environ Microbiol 2007; 73(20): 6404-9.